Livedo reticularis.
Chatterjee S.
Lancet Rheumatol. 2023 Mar;5(3):e166. doi: 10.1016/S2665-9913(22)00219-3. Epub 2022 Aug 22.
Sneddon Syndrome: A Comprehensive Overview.
Samanta D, Cobb S, Arya K.
J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2098-2108. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.013. Epub 2019 May 31.
Widespread livedo racemosa.
Zhao P, Luu LA, Gish TJ, Raghavan SS, Gru AA, Zlotoff BJ.
Clin Exp Dermatol. 2023 Jul 21;48(8):945-948. doi: 10.1093/ced/llad138.
Amantadine-Induced Livedo Racemosa.
Criado PR, Alavi A, Valente NY, Sotto MN.
Int J Low Extrem Wounds. 2016 Mar;15(1):78-81. doi: 10.1177/1534734615603566. Epub 2015 Sep 3.
Livedo Reticularis: An Enigma.
Sangle SR, D'Cruz DP.
Isr Med Assoc J. 2015 Feb;17(2):104-7.
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives.
Genovese G, Moltrasio C, Berti E, Marzano AV.
Dermatology. 2021;237(1):1-12. doi: 10.1159/000512932. Epub 2020 Nov 24.
Treatment for Livedoid Vasculopathy: A Systematic Review.
Micieli R, Alavi A.
JAMA Dermatol. 2018 Feb 1;154(2):193-202. doi: 10.1001/jamadermatol.2017.4374.
Livedo reticularis.
Rose AE, Sagger V, Boyd KP, Patel RR, McLellan B.
Dermatol Online J. 2013 Dec 16;19(12):20705.
Amantadine-induced livedo racemosa.
Chakraborty U, Banerjee S, Chandra A, Sil A.
BMJ Case Rep. 2024 Jan 12;17(1):e257492. doi: 10.1136/bcr-2023-257492.
Livedo racemosa.
Sebaratnam DF, Agar N.
Med J Aust. 2017 Oct 16;207(8):327. doi: 10.5694/mja16.01355.
